Alnylam Pharmaceuticals's annual revenues are $100-$500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Scientific Research & Development Services industry.
Note: Alnylam Pharmaceuticals's revenues are gauged from an analysis of company filings.
Trademark applications show the products and services that Alnylam Pharmaceuticals is developing and marketing.
Alnylam Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
AMVYTTRA Pharmaceutical preparations for the treatment of amyloidosis
AMVUTTRA Pharmaceutical preparations for the treatment of amyloidosis
RNAI EVIDENCE Maintaining a clinical registry database for patients with genetic mutations; maintaining a registry on the clinical outcomes in patients over time
Determine whether Alnylam Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Alnylam Pharmaceuticals is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Alnylam Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Alnylam Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Alnylam Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Alnylam Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.